This week's episode of Heads Up is Part II of Migraine, Headache Disorders, and the COVID Vaccine. Dr. Lindsay Weitzel discusses with Dr. Vincent Martin his experience with migraine patients after vaccination, concerns over certain migraine medicines and the vaccine, and what to take (or not take) if you experience a flare in your migraine or headache disorder after receiving the vaccine.

New data has shown that Aimovig (erenumab) is effective in treating intracranial hypertension, also known as high-pressure headache or pseudotumor cerebri. Dr. Lindsay Burgarello Weitzel and Dr. Timothy Smith discuss this exciting news for people living with this condition.

Dr. Timothy Smith and Dr. Lindsay Weitzel introduce us to a new non-invasive migraine treatment, Relivion. It is a brain neuromodulation device that has shown promise in treating migraine disease and a range of neurological and neuropsychiatric disorders. It offers highly effective treatment without the side effects associated with medications.

In this week's episode of Heads Up - Dr. Vince Martin and Dr. Lindsay Weitzel discuss COVID, the COVID vaccine, and migraine and headache disorders. Dr. Martin explains the headache/migraine experiences of patients who developed COVID. Find out if the COVID vaccine could have an impact on your migraine or headache disorder. For more information, please visit www.headaches.org

Teens and adolescents with migraine disease and chronic headache conditions have unique and significant stressors even under the best of circumstances. COVID has presented new conditions for this group, both positives and negative. In this episode of Heads Up, Dr. Lindsay Weitzel, Dr. Amy Gelfand, and Dr. Dawn Buse discuss the challenges and opportunities COVID presents to this age group of migraine patients.

Dr. Lindsay Weitzel and Dr. Timothy Smith discuss the FDA's recent approval of Nerivio for use in children older than 12 years of age. Nerivio is a smartphone-controlled wearable device used for the acute treatment of migraine.

British singer Jessie J woke up on Christmas Eve suffering from vertigo and experiencing a significant hearing loss. The 32-year-old singer was diagnosed with Meniere's disease. In Episode 84 of Heads UP, Dr. Lindsay Weitzel and Dr. Vincent Martin explain Meniere's disease and the relationship to migraine disease.

Dr. Timothy Smith and Dr. Lindsay Weitzel compare and contrast three oral gepants, an IV monoclonal antibody, two combination therapies, and an anti-inflammatory agent, all expected to be available for the treatment of migraine very soon. For more information visit www.headaches.org

Dr. Lindsay Weitzel and Dr. Timothy Smith discuss the National Headache Foundation's Certificate of Added Qualification in Headache Medicine (AQH). The program was started in 2000 in direct response to requests from people living with migraine disease and headache disorders. Patients expressed their difficulty in finding healthcare professionals who were trained in headache medicine.

Dr. Vincent Martin and Dr. Lindsay Weitzel discuss migraine triggers in this episode of Heads UP. Figuring out exactly what triggers your attacks is one of the ongoing struggles of migraine and headache patients. While no two patients experience migraine the same, there are some general areas of consideration when narrowing down the list. Determining personal triggers is a great starting point in learning to cope with and treat headache and migraine disease. To learn more about migraine disease and headache disorders, please visit www.headaches.org.